B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

AMINE

MOLECULAR TARGET

Amine oxidase [flavin-containing] A (human)

UniProt: P2139715 compounds

AMINE (Amine oxidase [flavin-containing] A (human)) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting AMINE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Moclobemide2.4010
2Iproniazid2.208
3Linezolid1.393
4Phenelzine1.393
5Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
6Resveratrol0.691
72-Acetylaminofluorene0.691
82-Hydroxypropyl-beta-cyclodextrin Derivative of beta-cyclodextrin that is used as0.691
9Ethynodiol Diacetate0.691
10Guanabenz0.691
11Harmaline0.691
12Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is0.691
13hispidol0.691
14pentamidine0.691
15Troglitazone0.691

About AMINE as a Drug Target

AMINE (Amine oxidase [flavin-containing] A (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented AMINE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

AMINE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.